New hope for kidney disease: BION-1301 trial underway

NCT ID NCT03945318

First seen Apr 21, 2026 · Last updated Apr 28, 2026 · Updated 2 times

Summary

This study tests a new medicine called BION-1301 in healthy people and adults with IgA nephropathy, a kidney disease. The goal is to check if the drug is safe and how the body processes it. About 103 participants will be involved in this early-stage trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Amicis Research Center

    Northridge, California, 91324, United States

  • Chris Sholer, P.C.

    Oklahoma City, Oklahoma, 73116, United States

  • Colorado Kidney Care, P.C.

    Denver, Colorado, 80230, United States

  • Elixia Tampa, LLC

    Tampa, Florida, 33618, United States

  • Hallym University Sacred Heart Hospital

    Anyang-si, Gyeonggi-do, 14068, South Korea

  • Hanyang University Guri Hostpital

    Guri-si, Gyeonggi-do, 11923, South Korea

  • Liberty Research Center

    Arlington, Texas, 76012, United States

  • Liberty Research Center

    Dallas, Texas, 75230, United States

  • Liverpool University Hospital NHS Foundation Trust

    Liverpool, England, L7 8XP, United Kingdom

  • National Health Insurance Service Ilsan Hospital

    Goyang-si, Gyeonggi-do, 10444, South Korea

  • Nephrology Associates of Central Florida

    Orlando, Florida, 32806, United States

  • New York Nephrology

    Clifton Park, New York, 12065, United States

  • PAREXEL Early Phase Clinical Unit

    London, HA1 3UJ, United Kingdom

  • Prolato Clinical Research Center

    Houston, Texas, 77054, United States

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Soon Chun Hyang University Hospital Cheonan

    Cheonan, Chungcheongnam-do, 31151, South Korea

Conditions

Explore the condition pages connected to this study.